Evidence map›Paper›PMID 26631602›Full record

ArticleJournal of chemical theory and computation2016

CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field.

Jumin Lee, Xi Cheng, Jason M Swails, Min Sun Yeom, Peter K Eastman, Justin A Lemkul, Shuai Wei, Joshua Buckner, Jong Cheol Jeong, Yifei Qi and 7 more

Abstract read
In one paragraph

Article in Journal of chemical theory and computation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2,213 papers.

0numbers the graph read from it
0cells of the map it votes in
2,213citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2,213 citing papers in PubMed.

  1. Article
  2. Structural dynamics and pH-regulated membrane binding of the TRAF2-NC trimer.Protein science : a publication of the Protein Society · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Understanding Biased Signaling and Small-Molecule Binding for Treatment of Type 2 Diabetes Mellitus and Obesity at the Glucagon-Like Peptide-1 Receptor (GLP-1R) Based on Molecular Dynamics Simulations.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

2,153 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jumin LeeDepartment of Molecular Biosciences and Center for Computational Biology, The University of Kansas , Lawrence, Kansas 66047, United States.
Xi ChengDepartment of Molecular Biosciences and Center for Computational Biology, The University of Kansas , Lawrence, Kansas 66047, United States.
Jason M SwailsDepartment of Chemistry and Chemical Biology, Rutgers University , Piscataway, New Jersey 08854, United States.
Min Sun YeomKorean Institute of Science and Technology Information , Yuseong-gu, Daejeon 305-806, Korea.
Peter K EastmanDepartment of Bioengineering, Stanford University , Stanford, California 94035, United States.
Justin A LemkulDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland , Baltimore, Maryland 21201, United States.
Shuai WeiDepartment of Chemistry and the Biophysics Program, University of Michigan , Ann Arbor, Michigan 48109, United States.
Joshua BucknerDepartment of Chemistry and the Biophysics Program, University of Michigan , Ann Arbor, Michigan 48109, United States.
Jong Cheol JeongCancer Research Institute, Beth Israel Deaconess Cancer Center, Harvard Medical School , Boston, Massachusetts 02215, United States.
Yifei QiDepartment of Molecular Biosciences and Center for Computational Biology, The University of Kansas , Lawrence, Kansas 66047, United States.
Sunhwan JoLeadership Computing Facility, Argonne National Laboratory , 9700 Cass Avenue, Building 240, Argonne, Illinois 60439, United States.
Vijay S PandeDepartment of Bioengineering, Stanford University , Stanford, California 94035, United States.
David A CaseDepartment of Chemistry and Chemical Biology, Rutgers University , Piscataway, New Jersey 08854, United States.
Charles L BrooksDepartment of Chemistry and the Biophysics Program, University of Michigan , Ann Arbor, Michigan 48109, United States.
Alexander D MacKerellDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland , Baltimore, Maryland 21201, United States.
Jeffery B KlaudaDepartment of Chemical and Biomolecular Engineering and the Biophysics Program, University of Maryland , College Park, Maryland 20742, United States.
Wonpil ImDepartment of Molecular Biosciences and Center for Computational Biology, The University of Kansas , Lawrence, Kansas 66047, United States.

Funding

Synthetic Antigen Binder CoreU54GM087519 · NIGMS · UNIVERSITY OF CHICAGO · PI BOWIE, JAMES U · 2010 to 2017
$31.9M
Polarizable Force Field for Proteins and LipidsR01GM072558 · NIGMS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI ROUX, BENOIT · 2005 to 2023
$5.1M
Theoretical Studies of Receptor-Ligand InteractionsR01GM037554 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROOKS, CHARLES L · 1987 to 2018
$3.8M
Oligonucleotide Conformational HeterogeneityR01GM051501 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI MACKERELL, ALEXANDER D · 2003 to 2018
$3.6M
Carbohydrate force fields for structure, dynamics and molecular recognitionR01GM070855 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI MACKERELL, ALEXANDER D · 2005 to 2018
$3.5M
CHARMM Modernization, Performance, and Continued DevelopmentR01GM103695 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROOKS, CHARLES L · 2012 to 2018
$3.1M
Exploring RNA Folding and Dynamics Using a Polarizable Force FieldF32GM109632 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI LEMKUL, JUSTIN ALAN · 2014 to 2016
$164k
HALOGEN FREE ENERGY DATABASE FOR RATIONAL DRUG DESIGNR29GM051501 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI MACKERELL, ALEXANDER D. · 1996 to 2000
$108k
NIGMS NIH HHS F32 GM109632NIGMS NIH HHS F32GM109632NIGMS NIH HHS GM037554NIGMS NIH HHS GM051501NIGMS NIH HHS GM070855NIGMS NIH HHS GM103695NIGMS NIH HHS R01 GM037554NIGMS NIH HHS R01 GM072558NIGMS NIH HHS R01GM072558NIGMS NIH HHS R01 GM103695NIGMS NIH HHS U54GM087519
6 · The paper itself

Abstract

Proper treatment of nonbonded interactions is essential for the accuracy of molecular dynamics (MD) simulations, especially in studies of lipid bilayers. The use of the CHARMM36 force field (C36 FF) in different MD simulation programs can result in disagreements with published simulations performed with CHARMM due to differences in the protocols used to treat the long-range and 1-4 nonbonded interactions. In this study, we systematically test the use of the C36 lipid FF in NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM. A wide range of Lennard-Jones (LJ) cutoff schemes and integrator algorithms were tested to find the optimal simulation protocol to best match bilayer properties of six lipids with varying acyl chain saturation and head groups. MD simulations of a 1,2-dipalmitoyl-sn-phosphatidylcholine (DPPC) bilayer were used to obtain the optimal protocol for each program. MD simulations with all programs were found to reasonably match the DPPC bilayer properties (surface area per lipid, chain order parameters, and area compressibility modulus) obtained using the standard protocol used in CHARMM as well as from experiments. The optimal simulation protocol was then applied to the other five lipid simulations and resulted in excellent agreement between results from most simulation programs as well as with experimental data. AMBER compared least favorably with the expected membrane properties, which appears to be due to its use of the hard-truncation in the LJ potential versus a force-based switching function used to smooth the LJ potential as it approaches the cutoff distance. The optimal simulation protocol for each program has been implemented in CHARMM-GUI. This protocol is expected to be applicable to the remainder of the additive C36 FF including the proteins, nucleic acids, carbohydrates, and small molecules.

Indexed as

Molecular Dynamics Simulation1,2-DipalmitoylphosphatidylcholineLipid BilayersPhosphatidylcholinesPhosphatidylethanolaminesPhosphatidylserinesSphingomyelins1,2-Dipalmitoylphosphatidylcholine1,2-oleoylphosphatidylcholine1-palmitoyl-2-oleoylglycero-3-phosphoserine1-palmitoyl-2-oleoylphosphatidylethanolamineLipid BilayerspalmitoylsphingomyelinPhosphatidylcholinesPhosphatidylethanolaminesPhosphatidylserinesSphingomyelins

Identifiers

PMID26631602
PMCPMC4712441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.